Brighter sells its stake in Camanio Care AB (publ) to related parties.

Brighter AB (publ) ("Brighter") has today decided to sell all of Brighter's shares and warrants in Camanio Care (the company that will remain after the business has been transferred to Camanio Care's subsidiary), to related parties as announced in a press release on September 8, 2019.

Prior to the sale, Brighter owned 14 500 000 shares and 371 544 warrants in Camanio Care. Of these, 7 250 000 shares and 185 722 warrants have been sold to Magnanimity AB, which is a company owned and controlled by Brighter's Executive Chairman Truls Sjöstedt. The other 7 250 000 shares and 185 722 warrants have been sold to Inti Raymi AB, which is a company owned and controlled by Brighter's CEO Henrik Norström.

The sales have been made on market terms. The price per share amounts to SEK 0.29, which corresponds to the volume-weighted average price during 20 trading days before the sale of the shares. The total purchase price for the shares and warrants transferred to Magnanimity AB and Inti Raymi AB amounts to SEK 4 205 000. The purchase price is paid in cash.

“The acquisition of Brighter's shares in Camanio Care AB (publ) by me and Henrik, through companies, is of private nature and not linked to Brighter. The company will continue to be public, but it will be renamed and have a completely new business orientation. In short, we want to establish a public investment company. Brighter will remain our primary focus area,” says Truls Sjöstedt.

For further information, please contact:

Henrik Norström, CEO   
Phone: +46 733 40 30 45      
Email: henrik.norstrom@brighter.se

Ann Zetterberg, CFO
Phone: +46 708 37 21 23
E-mail: ann.zetterberg@brighter.se

About Brighter AB (publ).
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/

The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 00, info@eminova.se, www.eminova.se.

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 19:00 CET on October 11, 2019.

About Us

Brighter is a Swedish health-tech company with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/ The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se

Subscribe

Documents & Links